{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:32:17Z","timestamp":1773480737645,"version":"3.50.1"},"reference-count":14,"publisher":"Media Sphere Publishing House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rus. Ann. Ophthal."],"published-print":{"date-parts":[[2025,9,8]]},"abstract":"<jats:p>Objective. This study evaluated changes in ocular parameters in patients with progressive myopia receiving 0.01% atropine. Material and methods. The study included 35 children (18 girls, 51.4%; and 17 boys, 48.6%) aged 4\u201415 years. Among them, 20 (57.2%) had one myopic parent and 2 (5.7%) had both parents with myopia. The study consisted of four stages: stage 1 \u2014 initial examination; stage 2 \u2014 follow-up after 8 months without treatment; stage 3 \u2014 follow-up after 12 months of treatment; stage 4 \u2014 follow-up 6 months after treatment cessation. Atropine 0.01% was instilled daily at bedtime in four courses of 1.5 months each, totaling 12 months of follow-up. All patients had an astigmatic component. Results. At stage 2, nearly all children showed progression of myopia, with a statistically significant increase in spherical equivalent in 63 (90%) eyes by an average of 0.70 D (p=0.000; p&lt;0.001). A similar trend was observed in axial length, which increased by 0.35\u00b10.09 mm (p=0.000; p&lt;0.001). At stage 3, stabilization was observed in both spherical equivalent and axial length. The mean difference in spherical equivalent between stages 2 and 3 was minor (\u22120.08 D) and not statistically significant (p=0.127; p&lt;0.050). Stabilization was also noted for axial length, with a change of 0.04 mm (p=0.034; p&lt;0.050). Differences between stages 3 and 4 in spherical equivalent were minimal and statistically insignificant (\u22120.01 D; p=0.012). Conclusion. The use of 0.01% atropine over one year in four 1.5-month courses stabilizes the progression of myopia in children. This method is an effective and acceptable option for controlling myopia in preschool and school-aged children.<\/jats:p>","DOI":"10.17116\/oftalma202514104129","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:25:10Z","timestamp":1757341510000},"page":"29","source":"Crossref","is-referenced-by-count":1,"title":["Clinical experience with 0.01% atropine for myopia control in children in Azerbaijan"],"prefix":"10.17116","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-2463","authenticated-orcid":false,"given":"A.P.","family":"Galbinur","sequence":"first","affiliation":[{"name":"Azerbaijan Medical University","place":["Baku, Azerbaijan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma202514104129-1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.006"},{"key":"key-10.17116\/oftalma202514104129-2","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2017133389-98"},{"key":"key-10.17116\/oftalma202514104129-3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.5.2"},{"key":"key-10.17116\/oftalma202514104129-4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.012"},{"key":"key-10.17116\/oftalma202514104129-5","doi-asserted-by":"publisher","DOI":"10.1097\/APO.0000000000000609"},{"key":"key-10.17116\/oftalma202514104129-6","unstructured":"Chiang MF, Kouzis A, Pointer RW, Repka MX. Treatment of childhood myopia with atropine eyedrops and bifocal spectacles. Binocular vision and strabismus quarterly. 2001;21(3):209-216"},{"key":"key-10.17116\/oftalma202514104129-7","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.13092"},{"key":"key-10.17116\/oftalma202514104129-8","doi-asserted-by":"crossref","unstructured":"Bullimore M, Berntsen D. Low-dose atropine for myopia control: considering all the data. JAMA Ophthalmology. 2018;136:303","DOI":"10.1001\/jamaophthalmol.2017.6638"},{"key":"key-10.17116\/oftalma202514104129-9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.1091"},{"key":"key-10.17116\/oftalma202514104129-10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.029"},{"key":"key-10.17116\/oftalma202514104129-11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.102094"},{"key":"key-10.17116\/oftalma202514104129-12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2022.09.024"},{"key":"key-10.17116\/oftalma202514104129-13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2023.01.030"},{"key":"key-10.17116\/oftalma202514104129-14","unstructured":"Aghayeva RB. Study of the overall morbidity rate of the eye diseases and its adnexa in adolescents 14 to 17 in the Azerbaijan Republic. Oftalmologiya. 2013;2(12):18-21. (In Russ.)"}],"container-title":["Russian Annals of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:25:23Z","timestamp":1757341523000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/vestnik-oftalmologii\/2025\/4\/10042465X2025041029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9,8]]}},"alternative-id":["10.17116\/oftalma202514104129"],"URL":"https:\/\/doi.org\/10.17116\/oftalma202514104129","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}